CSX Reaches Agreement with BMWED and BRC on Paid Sick Leave
JACKSONVILLE, Fla., Feb. 07, 2023 (GLOBE NEWSWIRE) -- CSX (NASDAQ: CSX) today announced that it has reached agreements with two unions that provide paid......
Tenaya Therapeutics to Participate in Upcoming Investor
SOUTH SAN FRANCISCO, Calif., Feb. 07, 2023 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a......
Matrix Service Company Updates Timing for Release of
TULSA, Okla., Feb. 07, 2023 (GLOBE NEWSWIRE) -- Matrix Service Company (Nasdaq: MTRX) previously announced release of results for the second quarter of......
Inari Medical to Announce Fourth Quarter and Full Year 2022
IRVINE, Calif., Feb. 07, 2023 (GLOBE NEWSWIRE) -- Inari Medical, Inc. (NASDAQ: NARI) (“Inari”), a medical device company with a mission to treat and......
EuroDry Ltd. Sets Date for the Release of Fourth Quarter
ATHENS, Greece, Feb. 07, 2023 (GLOBE NEWSWIRE) -- EuroDry Ltd. (NASDAQ: EDRY, the “Company” or “EuroDry”), an owner and operator of drybulk vessels and......
Mondelēz International to Present at CAGNY Conference on
CHICAGO, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Mondelēz International, Inc. (Nasdaq: MDLZ) announced that Dirk Van de Put, Chairman & CEO, Luca......
Outlook Therapeutics® to Present at the SVB Securities
– Russ Trenary, President and Chief Executive Officer of Outlook Therapeutics to present on Tuesday, February 14th at 4:20 PM ET –......
Clearside Biomedical OASIS Data to be Presented at Multiple
ALPHARETTA, Ga, Feb. 07, 2023 (GLOBE NEWSWIRE) -- Clearside Biomedical, Inc. (NASDAQ:CLSD), a biopharmaceutical company revolutionizing the delivery of......
2022 Fourth Quarter Earnings Conference Call Tuesday,
BETHLEHEM, Pa., Feb. 07, 2023 (GLOBE NEWSWIRE) -- OraSure Technologies, Inc. (NASDAQ: OSUR) has scheduled its regular earnings conference call covering......
iTeos to Present at SVB Securities Global Biopharma
WATERTOWN, Mass. and GOSSELIES, Belgium, Feb. 07, 2023 (GLOBE NEWSWIRE) -- iTeos Therapeutics, Inc. (Nasdaq: ITOS), a clinical-stage biopharmaceutical......